Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.

Also called NCT02035644

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 360 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02035644
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02035644. Randomized; double masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2015-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)
Condition
Dyslipidemia
Intervention (Drug)
Jinlida granules
Intervention (Drug)
placebo granules
Lead sponsor
Shanghai Jiao Tong University School of Medicine (class: other)
Collaborator
Shijiazhuang Yiling Pharmaceutical Co. Ltd (class: industry)

Record details

Record id
cardio:ct-nct02035644
Content hash
5198ab9fcd56070d309812e16b20d2e2bd2c0ac6750c2fdeaca2b5763b9fe33e